Literature DB >> 25030807

Predictors of mental health-related acute service utilisation and treatment costs in the 12 months following an acute psychiatric admission.

Dan Siskind1, Meredith Harris2, Sandra Diminic2, Georgia Carstensen2, Gail Robinson3, Harvey Whiteford2.   

Abstract

OBJECTIVE: A key step in informing mental health resource allocation is to identify the predictors of service utilisation and costs. This project aims to identify the predictors of mental health-related acute service utilisation and treatment costs in the year following an acute public psychiatric hospital admission.
METHOD: A dataset containing administrative and routinely measured outcome data for 1 year before and after an acute psychiatric admission for 1757 public mental health patients was analysed. Multivariate regression models were developed to identify patient- and treatment-related predictors of four measures of service utilisation or cost: (a) duration of index admission; and, in the year after discharge from the index admission (b) acute psychiatric inpatient bed-days; (c) emergency department (ED) presentations; and (d) total acute mental health service costs. Split-sample cross-validation was used.
RESULTS: A diagnosis of psychosis, problems with living conditions and prior acute psychiatric inpatient bed-days predicted a longer duration of index admission, while prior ED presentations and self-harm predicted a shorter duration. A greater number of acute psychiatric inpatient bed-days in the year post-discharge were predicted by psychosis diagnosis, problems with living conditions and prior acute psychiatric inpatient admissions. The number of future ED presentations was predicted by past ED presentations. For total acute care costs, diagnosis of psychosis was the strongest predictor. Illness acuity and prior acute psychiatric inpatient admission also predicted higher costs, while self-harm predicted lower costs. DISCUSSION: The development of effective models for predicting acute mental health treatment costs using existing administrative data is an essential step towards a workable activity-based funding model for mental health. Future studies would benefit from the inclusion of a wider range of variables, including ethnicity, clinical complexity, cognition, mental health legal status, electroconvulsive therapy, problems with activities of daily living and community contacts. © The Royal Australian and New Zealand College of Psychiatrists 2014.

Entities:  

Keywords:  Health service costs; mental disorders; mental health services; service utilisation

Mesh:

Year:  2014        PMID: 25030807     DOI: 10.1177/0004867414543566

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  4 in total

1.  Costs and outcomes for individuals with psychosis prior to hospital admission and following discharge in Bulgaria.

Authors:  Desislava Ignatova; Maria Kamusheva; Guenka Petrova; Georgi Onchev
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-03-30       Impact factor: 4.328

2.  A Secondary-Primary Mental Health Integrated Care Model for Communities with Diverse Population and Complex Health Needs - a Case Study with Health Care Utilization Evaluation.

Authors:  Clive Bensemann; Irene Suilan Zeng; Helen Hamer
Journal:  Int J Integr Care       Date:  2022-05-16       Impact factor: 2.913

3.  In-patient costs of agitation and containment in a mental health catchment area.

Authors:  Antoni Serrano-Blanco; Maria Rubio-Valera; Ignacio Aznar-Lou; Luisa Baladón Higuera; Karina Gibert; Alfredo Gracia Canales; Lisette Kaskens; José Miguel Ortiz; Luis Salvador-Carulla
Journal:  BMC Psychiatry       Date:  2017-06-06       Impact factor: 3.630

4.  Hospital length of stay variation and comorbidity of mental illness: a retrospective study of five common chronic medical conditions.

Authors:  Nazlee Siddiqui; Mitchell Dwyer; Jim Stankovich; Gregory Peterson; David Greenfield; Lei Si; Leigh Kinsman
Journal:  BMC Health Serv Res       Date:  2018-06-27       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.